Clinical trial
ALGRX 4975 in the Treatment of Tennis Elbow
NCT00130949 · AlgoRx Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00130949 |
|---|---|
| Title | ALGRX 4975 in the Treatment of Tennis Elbow |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Phase II, Exploratory Evaluation of ALGRX 4975 in Subjects With Acute Lateral Epicondylitis |
| Lead sponsor | AlgoRx Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tennis Elbow |
| Intervention type | Drug |
| Interventions | ALGRX 4975 |
| Enrollment | 45 |
| Start date | Nov 1, 2004 |
| Completion | Nov 1, 2005 |
| First posted | Aug 17, 2005 |
| Last update posted | Dec 20, 2006 |
| Countries | Slovakia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: